Preemptive plerixafor injection added to pegfilgrastim after chemotherapy in non-Hodgkin lymphoma patients mobilizing poorly-Reference-Cited by-同舟云学术

Preemptive plerixafor injection added to pegfilgrastim after chemotherapy in non-Hodgkin lymphoma patients mobilizing poorly

Published:2017-09-07 Issue:11 Volume:96 Page:1897-1906
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Partanen A.,Valtola J.,Ropponen A.,Vasala K.,Penttilä K.,Ågren L.,Pyörälä M.,Nousiainen T.,Selander T.,Mäntymaa P.,Pelkonen J.,Varmavuo V.,Jantunen E.

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/article/10.1007/s00277-017-3123-6/fulltext.html

Reference54 articles.

1. Jantunen E, Sureda A (2012) The evolving role of stem cell transplants in lymphomas. Biol Blood Marrow Transplant 18:660–673

2. Passweg JR, Baldomero H, Bader P et al (2017) Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society of Blood and Marrow Transplant activity survey report. Bone Marrow Transplant 52(6):811–817.

3. Isidori A, Tani M, Bonifazi F et al (2005) Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients. Haematologica 90:225–231

4. Kroschinsky F, Hölig K, Platzbecker U et al (2006) Efficacy of single-dose pegfilgrastim after chemotherapy for the mobilization of autologous peripheral blood stem cells in patients with malignant lymphoma or multiple myeloma. Transfusion 46:1417–1423

5. Nosari A, Cairoli R, Ciapanna D et al (2006) Efficacy of single dose pegfilgrastim in enhancing the mobilization of CD34+ peripheral blood stem cells in aggressive lymphoma patients treated with cisplatin-aracytin-containing regimens. Bone Marrow Transplant 387:413–416

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel PEGylated form of granulocyte colony-stimulating factor, mecapegfilgrastim, for peripheral blood stem cell mobilization in patients with hematologic malignancies;BMC Cancer;2023-07-24

2. High D‐index during mobilization predicts poor mobilization of CD34 + cells after anti‐lymphoma salvage chemotherapy;Journal of Clinical Apheresis;2021-10-23

3. Use of Plerixafor for Stem Cell Mobilization in the Setting of Autologous and Allogeneic Stem Cell Transplantations: An Update;Journal of Blood Medicine;2021-06

4. Mobilization characteristics, blood graft composition, and outcome in diffuse large B‐cell lymphoma after autologous stem cell transplantation: Results from the prospective multicenter GOA study;Transfusion;2020-11-27

5. Stromal cell-derived factor-1/CXC chemokine receptor 4 axis in injury repair and renal transplantation;Journal of International Medical Research;2019-10-03